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Keratoacanthoma centrifugum marginatum
(KCM) is a rare variant of keratoacanthoma (KA)
possessing several characteristics distinguishing it
from typical KAs. Clinical presentation deviates from
common KAs with lesions that continually expand
peripherally.1-3 KCM also deviates from the usual
histologic findings with a lack of some classic KA
features. This is probably attributable to sampling
issues given the size of the lesions and the limited
capacity of a biopsy. Because of its rarity and lack of
distinctive histopathologic features, KCM poses a
difficult diagnostic challenge to clinicians and
pathologists. Excellent communication and collabo-
ration between the clinician and the pathologist is
crucial for the correct and timely diagnosis, allowing
for quick and proper treatment of the patient.CASE PRESENTATION
We report a case of a 71-year-old white woman
with a single large erythematous tumor on her left
anterior knee. Originally, the lesion began as a single
erythematous papule after local trauma. She reports
the tumor expanded to an irregular 7.5- 3 3.5-cm
arciform, nonblanchable erythematous plaque
with hyperkeratotic papulonodular borders over
approximately 1 year (Fig 1).
An initial shave biopsy found irregular psoriasi-
form epidermal hyperplasia with squamous atypia.
The differential diagnosis consisted of unusual
psoriasis on stasis altered skin, pseudocarci-
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disorder; KCM; and squamous cell carcinoma.
Another biopsy a fewweeks later histopathologically
showed epidermal hyperplasia again, this time with
a dense mixed inflammatory infiltrate, and without a
dermal neoplasm or infectious organisms identified.
Concurrent bacterial, fungal, and mycobacterial
cultures returned negative. As a result, the patient
was treated with multiple rounds of topical steroids
without improvement. She also received 3 courses of
trimethoprim/sulfamethoxazole and 1 course of
doxycycline, each lasting approximately 10 days,
without any appreciable effect on the tumor.
Ultimately, a large incisional biopsy found zonal
changes from the periphery to the center of the
lesion. The outer lesion margin exhibited pseudoe-
pitheliomatous hyperplasia with underlying islands
of glassy, eosinophilic keratinocytes with squamous
pearls and minimal atypia in the dermal component.
Toward the center of the lesion were fibrosis and a
lack of epidermal hyperplasia (Figs 2 and 3). In the
dermis, both superficially and deep, was a mixed
infiltrate of lymphocytes, histiocytes, eosinophils,
neutrophils, and numerous plasma cells (Fig 4).
Again, no organisms were identified after
fungal, mycobacterial, and spirochete stains were
performed. Again, concurrent cultures returnedJAAD Case Reports 2016;2:206-8.
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Fig 1. Keratoacanthoma centrifugum marginatum. The
lesion began as a single erythematous papule that pro-
gressed to an irregular 7.5-3 3.5-cmboggy tumor on the left
anterior knee approximately 1 year after localized trauma.
Fig 2. A low-power view of the incisional biopsy with
zonal changes from the periphery to the center of the
lesion. The outer edge is characterized by pseudoepithe-
liomatous hyperplasia and a dense mixed inflammatory
infiltrate both superficially as well as deep. Centrally, the
lesion shows fibrosis and a lack of epidermal hyperplasia.
(Hematoxylin-eosin stain; original magnification: 32.)
Fig 3. A high-power view shows islands of keratinocytes
with squamous pearls and minimal atypia underlying
pseudoepitheliomatous hyperplasia. (Hematoxylin-eosin
stain; original magnification: 320.)
Fig 4. A high-power view shows the eosinophilic, glassy
cytoplasm of the keratinocytes, minimal atypia, and a
single mitotic figure near the basal layer. The dermal
inflammatory infiltrate is a mixture of lymphocytes,
histiocytes, eosinophils, and a few plasma cells.
(Hematoxylin-eosin stain; original magnification: 340.)
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aureus, corresponding to her superimposed infec-
tion. This lesion was diagnosed as compatible with
KCM. Because the lesion was too large to excise
entirely, the patient was treated with 2 courses of
intralesional 5% 5-fluorouracil injectable solution.
Each course consisted of 0.6 mL divided into 3
aliquots within the tumor mass, without precedent
lidocaine. The 2 treatments were separated by
3 weeks. The patient had no adverse events other
than discomfort at the time of injection. Treatment
resulted in complete clinical clearance of the lesion
within weeks (Fig 5). Follow-up at 2 years from
definitive diagnosis showed no evidence of
recurrence and no new lesions.
DISCUSSION
KAs are rapidly evolving tumors, composed
of keratinizing squamous cells arising from thefollicular infundibular epithelium. These lesions
are purported to resolve spontaneously if left
untreated.1-4 KAs typically occur on sun-exposed
skin in men past their fifth decade of life.1,2 They
usually present as firm, rounded, flesh-colored to red
papules with a keratin-filled central crater.1,3 These
lesions are usually solitary but can be multiple.4
Three stages characterize the growth course: initial
rapid growth, maturation, and spontaneous
involution, with each lasting 2 to 6 weeks.2,4 Of the
solitary forms, rare variants have been described to
include subungual type, intraoral and mucous
membrane type, giant KA, and marginated or
centrifugum type (also called KCM).3
KCM was first described by Miedzinski and
Kozakiewicz in 19625 and designated as a separate
entity in 1965 by Belisario.6 Its etiology is unclear but
appears to be multifactorial, including chronic
ultraviolet light exposure, smoking, and exposure
to chemical carcinogens.1 Unlike traditional KAs,
Fig 5. Clinical photo shows complete response within
weeks of receiving 2 courses of intralesional 5-fluorouracil
injections.
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our knowledge, there are currently no reported cases
of KCM associated with a solitary traumatic event.7,8
Our patient’s lesion, however, was noted to first
occur after trauma to this local area. KCM is
characterized by large lesions with progressive
peripheral extension, reaching up to 20 cm; raised,
rolled borders; and concomitant central healing
leading to atrophy.1-3 Unlike classic KAs, however,
KCM does not show a tendency for spontaneous
regression.1 Although locally disfiguring, the general
belief is that KCM is a benign entity, as no cases, to
our knowledge, have been reported to metastasize.1
Histopathologically, KCMs can look similar to
several other lesions. KCMs exhibit epidermal
hyperplasia, which may appear pseudoepitheliom-
atous with hyperkeratosis. There is often a dense
superficial and deep dermal mixed inflammatory
infiltrate. Cytologically, the keratinocytes appear
eosinophilic with glassy cytoplasm and minimal
number of mitoses.2,3 Thus, the differential diagnosis
may include an infectious etiology, specifically,
fungus or atypical mycobacterial, halogenoderma,
hypertrophic lupus erythematosus, giant KA, and
squamous cell carcinoma.1-3,9 With such a broad
differential diagnostic list, a lesion usually too large
to perform an excisional biopsy, and histologic
features that overlap those of many other lesions,
KCM requires an index of suspicion on both the
clinician’s and pathologist’s part.
Typically, surgical intervention is the preferred
therapy for solitary KAs; however, because of the
size of the lesions of KCM, this is not usually the mostfeasible therapy. There are reports of KCM being
treated with oral retinoids with variability
in success.3 Additionally, topical 5-fluorouracil,
intralesional injection of methotrexate, interferon
alfa, or bleomycin as well as Mohs surgery have
successfully been used, but no consensus regimens
have been established.1,4,9,10 No KCM lesions, to our
knowledge, have been successfully treated with
intralesional 5-flurouracil injection until our case,
with complete response and regression of the tumor.CONCLUSION
KCM is a rare variant of KA, with its diagnosis
complicated by its rarity and lack of distinctive
histopathologic features. Although trauma has been
implicated as an etiologic factor in typical KAs, this is
the first report, to our knowledge, that associates
KCM with a traumatic event. Additionally, we pre-
sent the first successful treatment of KCM with
intralesional 5-fluorouracil injection.
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